FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1797236870> ?p ?o ?g. }

• W1797236870 endingPage "1674" @default.
• W1797236870 startingPage "1664" @default.
• W1797236870 abstract "A total of 342 previously untreated eligible children were entered into the first Intergroup Ewing's Sarcoma Study (IESS) between May 1973 and November 1978. In group I institutions, patients were randomized between treatment 1 (radiotherapy to primary lesion plus cyclophosphamide, vincristine, dactinomycin, and Adriamycin [doxorubicin; Adria Laboratories, Columbus, OH] [VAC plus ADR]) or treatment 2 (same as treatment 1 without ADR), and group II institutions randomized patients between treatment 2 or treatment 3 (same as treatment 2 plus bilateral pulmonary radiotherapy [VAC plus BPR]). The percentages of patients relapse-free and surviving (RFS) at 5 years for treatments 1, 2, and 3 were 60%, 24%, and 44%, respectively. There was strong statistical evidence of a significant advantage in RFS for treatment 1 (VAC plus ADR) versus 2 (VAC alone) (P less than .001) and 3 (P less than .05) and also of treatment 3 versus 2 (P less than .001). Similar significant results were observed with respect to overall survival. Patients with disease at pelvic sites have significantly poorer survival at 5 years than those with disease at nonpelvic sites (34% v 57%; P less than .001). Among pelvic cases, there was no evidence of differing survival by treatment (P = .81), but among nonpelvic cases, there was strong evidence of differing survival by treatment (P less than .001). The overall percentage of patients developing metastatic disease was 44%; the percentages by treatments 1, 2, and 3 were 30%, 72%, and 42%, respectively. The overall incidence of local recurrence was 15%, and there was no evidence that local recurrence rate differed by treatment. Patient characteristics related to prognosis, both with respect to RFS and overall survival experience, were primary site (nonpelvic patients were most favorable) and patient age (younger patients were more favorable)." @default.
• W1797236870 created "2016-06-24" @default.
• W1797236870 creator A5003023806 @default.
• W1797236870 creator A5003604864 @default.
• W1797236870 creator A5007275900 @default.
• W1797236870 creator A5018033699 @default.
• W1797236870 creator A5047990345 @default.
• W1797236870 creator A5069294459 @default.
• W1797236870 creator A5081276533 @default.
• W1797236870 creator A5083012918 @default.
• W1797236870 creator A5088348230 @default.
• W1797236870 creator A5088939298 @default.
• W1797236870 date "1990-10-01" @default.
• W1797236870 modified "2023-10-10" @default.
• W1797236870 title "Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study." @default.
• W1797236870 cites W1979300931 @default.
• W1797236870 cites W2020022293 @default.
• W1797236870 cites W2028800748 @default.
• W1797236870 cites W2084145198 @default.
• W1797236870 cites W2139984188 @default.
• W1797236870 cites W2143594378 @default.
• W1797236870 cites W2150290224 @default.
• W1797236870 cites W2224494804 @default.
• W1797236870 cites W2239269703 @default.
• W1797236870 cites W2243173476 @default.
• W1797236870 doi "https://doi.org/10.1200/jco.1990.8.10.1664" @default.
• W1797236870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2213103" @default.
• W1797236870 hasPublicationYear "1990" @default.
• W1797236870 type Work @default.
• W1797236870 sameAs 1797236870 @default.
• W1797236870 citedByCount "511" @default.
• W1797236870 countsByYear W17972368702012 @default.
• W1797236870 countsByYear W17972368702013 @default.
• W1797236870 countsByYear W17972368702014 @default.
• W1797236870 countsByYear W17972368702015 @default.
• W1797236870 countsByYear W17972368702016 @default.
• W1797236870 countsByYear W17972368702017 @default.
• W1797236870 countsByYear W17972368702018 @default.
• W1797236870 countsByYear W17972368702019 @default.
• W1797236870 countsByYear W17972368702020 @default.
• W1797236870 countsByYear W17972368702021 @default.
• W1797236870 countsByYear W17972368702022 @default.
• W1797236870 countsByYear W17972368702023 @default.
• W1797236870 crossrefType "journal-article" @default.
• W1797236870 hasAuthorship W1797236870A5003023806 @default.
• W1797236870 hasAuthorship W1797236870A5003604864 @default.
• W1797236870 hasAuthorship W1797236870A5007275900 @default.
• W1797236870 hasAuthorship W1797236870A5018033699 @default.
• W1797236870 hasAuthorship W1797236870A5047990345 @default.
• W1797236870 hasAuthorship W1797236870A5069294459 @default.
• W1797236870 hasAuthorship W1797236870A5081276533 @default.
• W1797236870 hasAuthorship W1797236870A5083012918 @default.
• W1797236870 hasAuthorship W1797236870A5088348230 @default.
• W1797236870 hasAuthorship W1797236870A5088939298 @default.
• W1797236870 hasConcept C120665830 @default.
• W1797236870 hasConcept C121332964 @default.
• W1797236870 hasConcept C126322002 @default.
• W1797236870 hasConcept C141071460 @default.
• W1797236870 hasConcept C142724271 @default.
• W1797236870 hasConcept C168563851 @default.
• W1797236870 hasConcept C2776694085 @default.
• W1797236870 hasConcept C2776755627 @default.
• W1797236870 hasConcept C2778256501 @default.
• W1797236870 hasConcept C2779429289 @default.
• W1797236870 hasConcept C2781303535 @default.
• W1797236870 hasConcept C509974204 @default.
• W1797236870 hasConcept C61511704 @default.
• W1797236870 hasConcept C71924100 @default.
• W1797236870 hasConcept C90924648 @default.
• W1797236870 hasConceptScore W1797236870C120665830 @default.
• W1797236870 hasConceptScore W1797236870C121332964 @default.
• W1797236870 hasConceptScore W1797236870C126322002 @default.
• W1797236870 hasConceptScore W1797236870C141071460 @default.
• W1797236870 hasConceptScore W1797236870C142724271 @default.
• W1797236870 hasConceptScore W1797236870C168563851 @default.
• W1797236870 hasConceptScore W1797236870C2776694085 @default.
• W1797236870 hasConceptScore W1797236870C2776755627 @default.
• W1797236870 hasConceptScore W1797236870C2778256501 @default.
• W1797236870 hasConceptScore W1797236870C2779429289 @default.
• W1797236870 hasConceptScore W1797236870C2781303535 @default.
• W1797236870 hasConceptScore W1797236870C509974204 @default.
• W1797236870 hasConceptScore W1797236870C61511704 @default.
• W1797236870 hasConceptScore W1797236870C71924100 @default.
• W1797236870 hasConceptScore W1797236870C90924648 @default.
• W1797236870 hasIssue "10" @default.
• W1797236870 hasLocation W17972368701 @default.
• W1797236870 hasLocation W17972368702 @default.
• W1797236870 hasOpenAccess W1797236870 @default.
• W1797236870 hasPrimaryLocation W17972368701 @default.
• W1797236870 hasRelatedWork W1978070076 @default.
• W1797236870 hasRelatedWork W2036802760 @default.
• W1797236870 hasRelatedWork W2083438316 @default.
• W1797236870 hasRelatedWork W2087146189 @default.
• W1797236870 hasRelatedWork W2111618869 @default.
• W1797236870 hasRelatedWork W2145349532 @default.
• W1797236870 hasRelatedWork W2330662417 @default.
• W1797236870 hasRelatedWork W2342164759 @default.
• W1797236870 hasRelatedWork W2418155614 @default.

• next